Finance

Lists
Why is SKYE up 2,58%?
Dive Deeper
SKYE:NASDAQ
Skye Bioscience Inc
1,59 USD
+2,58%
(+0,040) 1D
19-окт., 09:57:44 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SKYE...
Open
1,57 USD
High
1,59 USD
Low
1,57 USD
Mkt. cap
7,04 млн
Avg. vol.
65,27 миң
Volume
2,40 миң
52-wk high
13,28 USD
52-wk low
1,50 USD
EPS
-10,18 USD
Beta
2,86
Shares outstanding
4,43 млн
No. of employees
2
Open
1,57 USD
High
1,59 USD
Low
1,57 USD
Mkt. cap
7,04 млн
Avg. vol.
65,27 миң
Volume
2,40 миң
52-wk high
13,28 USD
52-wk low
1,50 USD
EPS
-10,18 USD
Beta
2,86
Shares outstanding
4,43 млн
No. of employees
2
News stories
From web sources and news partners
About Skye Bioscience Inc
CEO-
Employees2
Founded2011
Headquarters-
Sector-
Analyst
Recommendation
Action
Price target
Projected
Date
Ananda Ghosh
H.C. Wainwright
Buy
Maintained
20,00 USD
+1 157,9%
05/21/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
6,00 USD
+277,4%
05/12/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
05/12/2026
Jay Olson
Oppenheimer
Buy
Maintained
10,00 USD
+528,9%
03/11/2026
Kristen Kluska
Cantor Fitzgerald
Hold
Maintained
2,00 USD
+25,8%
03/10/2026
Albert Lowe
Craig-Hallum
Hold
Maintained
-
-
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9,36 млн
11,47 млн
7,94 млн
3,94 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,91 млн
3,43 млн
4,74 млн
3,87 млн
Operating expense
13,26 млн
14,90 млн
12,67 млн
7,81 млн
Total operating expenses
13,26 млн
14,90 млн
12,67 млн
7,81 млн
Operating income
-13,26 млн
-14,90 млн
-12,67 млн
-7,81 млн
Other non operating income
-
-502,00
-2,41 миң
-
EBT including unusual items
-12,75 млн
-14,44 млн
-12,51 млн
-10,78 млн
EBT excluding unusual items
-12,85 млн
-14,62 млн
-12,51 млн
-7,71 млн
Income tax expense
-
-
-
3,40 миң
Effective tax rate
-
-
-
-0,03%
Other operating expenses
-
-
-
-
Net income
-12,75 млн
-14,44 млн
-12,51 млн
-10,79 млн
Net profit margin
-
-
-
-
Earnings per share
-2,59
-2,95
-2,56
-1,55
Interest and investment income
418,47 миң
274,10 миң
169,62 миң
103,21 миң
Interest expense
-
-
-2,20 миң
-3,30 миң
Net interest expenses
418,47 миң
274,10 миң
167,42 миң
99,91 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-13,09 млн
-14,72 млн
-12,50 млн
-7,65 млн
Gain or loss from assets sale
-91,40 миң
-179,99 миң
7,62 миң
411,46 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору